











































Epidemic waves of COVID-19 in Scotland: a genomic perspective
on the impact of the introduction and relaxation of lockdown on
SARS-CoV-2
Citation for published version:
Lycett, SJ, Hughes, J, McHugh, MP, Filipe, ADS, Dewar, R, Lu, L, Doherty, T, Shepherd, A, Inward, R,
Rossi, G, Balaz, D, Kao, RR, Rooke, S, Cotton, S, Gallagher, MD, Lopez, CB, O’Toole, Á, Scher, E, Hill, V,
McCrone, JT, Colquhoun, RM, Jackson, B, Williams, TC, Williamson, KA, Johnson, N, Smollett, K, Mair, D,
Carmichael, S, Tong, L, Nichols, J, Brunker, K, Shepherd, JG, Li, K, Aranday-Cortes, E, Parr, YA, Broos, A,
Nomikou, K, McDonald, SE, Niebel, M, Asamaphan, P, Starinskij, I, Jesudason, N, Shah, R, Sreenu, VB,
Stanton, T, Shaaban, S, MacLean, A, Woolhouse, M, Gunson, R, Templeton, K, Thomson, EC, Rambaut,
A, Holden, MTG & Robertson, DL 2021 'Epidemic waves of COVID-19 in Scotland: a genomic perspective
on the impact of the introduction and relaxation of lockdown on SARS-CoV-2' Cold Spring Harbor
Laboratory Press. https://doi.org/10.1101/2021.01.08.20248677,
https://doi.org/10.1101/2021.01.08.20248677




Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.




Epidemic waves of COVID-19 in Scotland: a genomic perspective on the impact 
of the introduction and relaxation of lockdown on SARS-CoV-2  
 
Samantha J Lycett1, Joseph Hughes2, Martin P McHugh3,11, Ana da Silva Filipe2, Rebecca 
Dewar3, Lu Lu4, Thomas Doherty1, Amy Shepherd1, Rhys Inward1, Gianluigi Rossi1, Daniel 
Balaz1, Rowland R Kao1, Stefan Rooke5, Seb Cotton3, Michael D Gallagher1, Carlos Balcazar 
Lopez3, Áine O’Toole5, Emily Scher5, Verity Hill5, John T McCrone5, Rachel M Colquhoun5, 
Ben Jackson5, Thomas C Williams6, Kathleen A Williamson6, Natasha Johnson2, Katherine 
Smollett2, Daniel Mair2, Stephen Carmichael2, Lily Tong2, Jenna Nichols2, Kirstyn Brunker7, 
James G Shepherd2, Kathy Li2, Elihu Aranday-Cortes2, Yasmin A Parr2, Alice Broos2, Kyriaki 
Nomikou2; Sarah E McDonald2, Marc Niebel2, Patawee Asamaphan2, Igor Starinskij8, 
Natasha Jesudason2, Rajiv Shah2, Vattipally B Sreenu2, Tom Stanton9, Sharif Shaaban10, 
Alasdair MacLean8, The COVID-19 Genomics UK (COG-UK) consortium12, Mark 
Woolhouse4, Rory Gunson8, Kate Templeton3, Emma C Thomson2, Andrew Rambaut5, 
Matthew T.G. Holden10,11, David L Robertson2  
 
1Roslin Institute, University of Edinburgh; 2MRC-University of Glasgow Centre for Virus 
Research (CVR); 3Virology Department, Royal Infirmary of Edinburgh, NHS Lothian; 4Usher 
Institute, University of Edinburgh;  5Institute of Evolutionary Biology, University of Edinburgh; 
6MRC Institute of Genetics and Molecular Medicine, University of Edinburgh; 7Institute of 
Biodiversity, Animal Health and Comparative Medicine, Boyd Orr Centre for Population and 
Ecosystem Health, University of Glasgow;  8West of Scotland Specialist Virology Centre, 
NHSGGC and University of Edinburgh;  9Edinburgh Medical School, University of Edinburgh; 
10Public Health Scotland; 11School of Medicine, University of St Andrews; 
12https://www.cogconsortium.uk. Full list of consortium names and affiliations are in the 
appendix in the authorship.  
 
Correspondence: samantha.lycett@ed.ac.uk; david.l.robertson@glasgow.ac.uk  
 
Abstract 
The second SARS virus, SARS-CoV-2, emerged in December 2019, and within a month was 
globally distributed. It was first introduced into Scotland in February 2020 associated with 
returning travellers and visitors. By March it was circulating in communities across the UK, 
and to control COVID-19 cases, and prevent overwhelming of the National Health Service 
(NHS), a ‘lockdown’ was introduced on 23rd March 2020 with a restriction of people’s 
movements. To augment the public health efforts a large-scale genome epidemiology effort 
(as part of the COVID-19 Genomics UK (COG-UK) consortium) resulted in the sequencing 
of over 5000 SARS-CoV-2 genomes by 18th August 2020 from Scottish cases, about a 
quarter of the estimated number of cases at that time. Here we quantify the geographical 
origins of the first wave introductions into Scotland from abroad and other UK regions, the 
spread of these SARS-CoV-2 lineages to different regions within Scotland (defined at the 
level of NHS Health Board) and the effect of lockdown on virus ‘success’. We estimate that 
approximately 300 introductions seeded lineages in Scotland, with around 25% of these 
lineages composed of more than five viruses, but by June circulating lineages were reduced 
to low levels, in line with low numbers of recorded positive cases. Lockdown was, thus, 
associated with a dramatic reduction in infection numbers and the extinguishing of most virus 
lineages. Unfortunately since the summer cases have been rising in Scotland in a second 
wave, with >1000 people testing positive on a daily basis, and hospitalisation of COVID-19 
cases on the rise again. Examining the available Scottish genome data from the second 
wave, and comparing it to the first wave, we find that while some UK lineages have persisted 
through the summer, the majority of lineages responsible for the second wave are new 
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introductions from outside of Scotland and many from outside of the UK. This indicates that, 
while lockdown in Scotland is directly linked with the first wave case numbers being brought 
under control, travel-associated imports (mostly from Europe or other parts of the UK) 
following the easing of lockdown are responsible for seeding the current epidemic population. 
This demonstrates that the impact of stringent public health measures can be compromised 
if following this, movements from regions of high to low prevalence are not minimised.  
 
Introduction 
In 2002/03 a new human coronavirus, SARS-CoV, emerged from horseshoe bats in China. 
These outbreaks were controlled by public health interventions and the total number of 
infected people was held at about 8000, deaths to 774, and virus eradication achieved 
(Anderson et al. 2004). Subsequent surveillance efforts for SARS-like viruses identified a 
reservoir of Severe acute respiratory syndrome-related coronaviruses in horseshoe bats and 
warned of risks for future spill over (Li et al. 2005, Menachery et al. 2015). A virus of the same 
species, named SARS-CoV-2 (Gorbalenya et al. 2020), was detected in a cluster of infections 
in Wuhan city, China, in December 2019. The first COVID-19 death occurred on the 11th 
January and by the 24th January, there were >800 confirmed cases and 17 deaths recorded 
(Wang et al. 2020). A pandemic was declared by the WHO on the 12th March 2020 and 
Europe became the epi-centre of the SARS-CoV-2 pandemic.  
 
As of November 2020 there have been >58 million cases recorded and >1.4 million deaths 
due to COVID-19. These numbers are despite the use of unprecedented  non-pharmaceutical 
public health interventions to restrict virus transmission. For example, on the 23rd January 
the first ‘lockdown’ was imposed on several cities in Hubei province. While efforts to control 
spread in China were largely successful owing to strict use of control measures -- with 
reported deaths being below 5,000, 10 times fewer deaths than the UK despite a population 
20 times larger (Burki 2020) -- the control of people’s movement on an unprecedented scale, 
coupled with damage to economies, has made lockdowns controversial. Here, by taking a 
genomics perspective, we analyse the response in the UK with a focus on Scotland. 
 
Genome-based studies of the SARS-CoV-2 variants in different geographical regions 
identified multiple introductions associated with international travel routes (for example, 
(Bugembe et al. 2020, Tayoun et al. 2020, Worobey et al. 2020). The introductions to the UK 
(>1400 events) have been recorded to early February and throughout that month (20% of 
transmission lineages) with the majority (80%) being established in March (Plessis et al. 
2020). By the end of March we have estimated there were at least 283 introductions of SARS-
CoV-2 into Scotland, the first recorded case being the 28th February, and phylogenetic 
analysis suggests an earlier introduction around the 19th February (Filipe et al. 2020). As the 
proportion of infected individuals increased markedly, and without access to suitable 
treatments, it became clear health services would struggle to cope with those with severe 
disease and a UK stay-at-home lockdown began on the 23rd March.  
 
As part of the public health response, the COVID-19 Genomics UK (COG-UK) consortium, 
was formed to sequence and analyse the genetic material of SARS-CoV-2 as it spread in the 
four regions: England, Northern Ireland, Scotland and Wales. The consortium applies 
genomic sequencing technologies to the UK epidemic and provides crucial information on 
the surveillance of the circulating variants and on virus spread, contributing to local 
epidemiological investigations, monitoring of hospital-associated transmissions and 
nosocomial infections, and the study of the evolution of the virus, for example, of variants of 
antigenic significance. In this paper we focus on the spread of the dominant SARS-CoV-2 
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lineages that were introduced into Scotland and the association between lockdown and their 
circulation. We compare these first wave (a period from February 2020 to the easing of 
restrictions in July 2020) lineages to the variants responsible for the second wave (a period 
from August 2020 onwards). The two main lessons to be learned are (i) the lockdown was 
associated with a highly effective reduction in infection numbers and virus diversity, and (ii) 
once the virus is brought under control, restricting movement into geographical regions with 
very low prevalence is important to prevent re-introductions and the overwhelming of public 
health efforts.  
 
Results 
The first wave -- diversity of lineages seen in Scotland. SARS-CoV-2 sequences can be 
classified into distinct lineages (Rambaut et al. 2020). Of the 164 named lineages in the global 
dataset 101 are present in the UK reflecting the broad diversity of the SARS-CoV2 
introductions into the UK and confirming our previous analysis to the end of March 2020 
(Filipe et al. 2020). Sequences classified as lineage B.1 and B.1.1 account for over 50% both 
globally and for the UK as a whole. Of the global diversity, a wide sample was introduced into 
Scotland (Supplementary figure 1), and representatives of 55 of the named global lineages 
are observed. 40% of the Scottish sequences were B.1 and B.1.1. Reflecting different travel 
patterns, there was a higher proportion of B.1.5 in Scotland than the rest of the UK (6% of 
Scotland sequences, <2% rest of UK); and global lineage B.1.93 was almost exclusive to 
Scotland (representing 14% of Scotland sequences, but only 12 sequences from the rest of 
the UK). Lineages with a greater total number of sequences in Scotland than the rest of UK, 
and for which there are significantly more sequences sampled (Fisher test, P<0.0001, and 
Bonferroni correction) are: A.2, A.3, A.5, B.1.1.12, B.1.1.14, B.1.1.20, B.1.1.28, B.1.100, 
B.1.101, B.1.40, B.1.5.10, B.1.69, B.1.70, B.1.71, B.1.77, B.1.89, B.1.9, B.1.90, B.1.93, B.16, 
presumably reflecting different travel destinations as we previously reported (Filipe et al. 
2020).  
 
This SARS-CoV-2 diversity circulating in Scotland is spread across the different regions of 
the country with variants from the global lineages intermingling in the different NHS Health 
Boards (Figure 1A), which represent the regional organisation of the NHS within Scotland. 
Importantly, the number of patient samples for which genome sequences have been 
obtained, 5137 genomes by the 18th August 2020, captures sufficiently (at about ~25% of 
tested positive cases) the distribution of infections in Scotland since March (Figure 1Bl). It is 
important to appreciate that modelled prevalence estimates indicate that the number of 
recorded positive tests are only a fraction of the true number of cases. 
 
A sampling strategy (see Methods) was followed to ensure representation of all of the regions 
of Scotland and relative frequencies of infections in the 14 Scottish NHS Health Boards 
(Figure 2). This high-coverage genome-level surveillance data demonstrates a clear rise and 
fall of COVID-19 in line with recorded cases (Figure 1B), and its resolution, among the highest 
in the world for a relatively small population (~5.5 million people), permits a detailed 
characterisation of the spread of the virus within a single country. First, however, in order to 
track spread it is necessary to infer the distinct lineages associated with the introductions of 
SARS-CoV-2 into Scotland from other parts of the UK and globally. 
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Figure 1. A| SARS-CoV-2 diversity circulating in Scotland up to 18th August 2020 represented by 
phylogenetic tree (inferred with TimeTree) with Scottish NHS Health Board focus (see key). B| the 
number of sequences (in black) versus the recorded positive cases by Scottish NHS Health Board 
plotted on the same time scale. The four vertical dashed lines represent the beginning of the lockdown 
(23rd March 2020) and its easing: movement to phase 1 (29th March 2020), phase 2 (19th June 2020) 
and phase 3 (10th July 2020).  
 
The first wave -- estimates of introductions into Scotland pre-lockdown. Using a simple 
model to assign discrete locations to the ancestral nodes in the phylogeny (see Methods), 
the number of changes in the phylogeny from locations outside Scotland into Scotland were 
estimated. This gives an indication of the total number of imports, but is dependent on (and 
heavily biased by) the number of sequences sampled from different countries (some which 
are very low so unreliable) and the uncertainty and resolution in the phylogenetic tree. Using 
this approximate measure, we estimate 307 imports and 158 exports to and from Scotland 
respectively over the whole date range (Supplementary figure 2), close to our previous 
analysis (Filipe et al. 2020) where we estimated >283 introductions based on sequences 
sampled to the end March and known travel histories. With the caveat that sampling for non-
UK regions can be sparse, most of these imports (50%) appear to come from England, 24% 
from the rest of Europe, and 7-8% each from Wales, Asia and North America (Supplementary 
figure 2A). The estimated proportion of the total exports that went back into England and 
Europe are lower than the imports (34% and 18% respectively), but the proportion is higher 
for Wales (9%), and North America (27%). The proportion of all exports from Scotland into 
mainland Europe (subject to some biases, see Methods) was approximately the same as the 
proportion of imports.  
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Figure 2. SARS-CoV-2 genome sequence counts by A| Scottish Health Board, and B| by sampling 
time from 28th February to 18th August 2020. 
 
A similar approach to estimate the number of location changes in the phylogeny from non-
UK to UK resulted in 1540 introduced lineages, of which 283 were found in Scotland. Of these 
283 lineages, most (217) are represented by five variants or less (154 by only one), leaving 
66 lineages represented by >five variants. These introductions to the UK were estimated from 
the global tree, and each introduction was given a ‘UK lineage number’ (see Methods). Some 
introductions gave rise to many subsequent infections in all parts of the UK, for example, the 
first sequences being sampled from places in England, and then subsequently sampled from 
places in Scotland. Other introduced lineages were first sampled in Scotland. Note, the 
number of introductions estimated from the number of lineages is not quite the same as the 
approximate import count above (Supplementary figure 2), because a lineage can be 
transmitted between the different UK regions on more than one occasion, e.g., England and 
Scotland, but only counted as imported to the UK once.  
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Using the sequences grouped into UK lineages, and also including other closely related 
sequences (from other UK lineages or sequences from outside the UK) in ‘extended’ 
lineages, we estimated time-scaled trees for each lineage/cluster. This permitted the 
inference of the ancestral locations of the internal nodes in the phylogeny (see Methods). 
Supplementary figure 2B summarises the start time of the UK lineages which have 
sequences in Scotland, along with their inferred ancestral locations, i.e., the time to most 
recent common ancestor of the sequences within the lineage within Scotland, and the 
location of their direct ancestral node. UK lineages in Scotland which have such direct 
ancestors estimated to be in Scotland are also included, e.g., when two Scottish lineages are 
detected, but they both go back to the same multifurcating ancestral node.  
 
The first wave -- distribution of diversity within Scotland over time. Looking at the 
different regions of Scotland (defined by NHS Health Boards) we can track both the diversity 
of the UK lineages circulating in a local region and how imports versus exports to other 
regions within Scotland change through time (Figure 3). This demonstrates how, once 
introduced, the virus spread rapidly within Scotland. Of the NHS Health Boards, NHS 
Glasgow and Greater Clyde has a large number of exports (and imports) to NHS Tayside 
and England pre-lockdown (Figure 4). This continues during lockdown and shows a high 
number of exports to NHS Lanarkshire with an increase in exports following lockdown. NHS 
Lothian (Figure 4) also shows a high number of exports to England (Supplementary figure 3 
and http://sars2.cvr.gla.ac.uk/RiseFallScotCOVID/). On imports pre-lockdown NHS Greater 
Glasgow and Clyde has a relatively large number of imports from England (246) as does 
NHS Lothian (175), and this reduces to 44 and 45 respectively during lockdown. These 
estimates for other NHS Health Boards can be seen in Supplementary figure 3, with a 
summary of the number of imports and exports into each region. 
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Figure 3. Maps showing the import and export relationships between the NHS Health Boards within 
Scotland at different timepoints from March to June. A time lapse video is available at 
http://sars2.cvr.gla.ac.uk/RiseFallScotCOVID/ Results for Orkney, Shetland and the Western Isles are 
not included as sequence numbers are too low for these regions. 
 
The effect of lockdown. Although there was a lag from the start of the epidemic and the 
time the lockdown was imposed on the 23rd March, it can be directly linked with a substantial 
reduction in the number of COVID-19 cases, circulating SARS-CoV-2 variants and diversity 
in Scotland (Figure 4 and see Supplementary figures 3 and 4). The majority of lineages 
circulating decreased markedly and limited intra-country spread is observed by June (Figure 
3). Interestingly for larger lineages there is a lag in lineage extinction with the time between 
observation of variants increasing steadily. The phylogenetic diversity in each NHS Health 
Board can be tracked through time (Supplementary figure 4). It can be seen that lockdown is 
associated with an immediate change in the diversity in the less populous NHS Health Boards 
but, not unexpectedly, a more delayed change in more populous regions, for example, in 
NHS Greater Glasgow and Clyde, NHS Lothian and NHS Lanarkshire the diversity only 
started decreasing 3-4 weeks after lockdown. However, that lockdown coincided with the 
elimination the majority of community transmissions in Scotland is clear from the data. 
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Figure 4. Timing of the imports and exports to Scottish NHS Health Board using NHS Greater Clyde and 
Glasgow and NHS Lothian as examples. See Supplementary figure 3 (and 
http://sars2.cvr.gla.ac.uk/RiseFallScotCOVID/) for other NHS Health Boards and a summary of the number of 
imports and exports into each region. The three plots for each NHS Health Board are as follows: top plot -- 
imports coloured by first NHS Health Board lineage detected in (rainbow colours) or England (red), Wales 
(green), Northern Ireland (purple). Note that the England (red) is a major source for both NHS Greater Glasgow 
and Clyde and Lothian in March; second row plot -- exports (same colouring as imports); third row plot -- 
number of sequences per NHS Health Board coloured by UK lineage number (other rainbow colours). 
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Lineage dynamics in Scotland. SARS-CoV-2 variants enter and spread within the UK and 
Scotland, forming clusters and complex transmission chains. These chains or even whole 
lineages may die out due to stochastic epidemiological processes (even if R0>1, although 
the probability is lower than for R0<1), or due to the success of non-pharmaceutical  
restrictions in reducing transmission. Figure 5 (top) shows the number of sequences from 
Scotland available up until 21st October 2020, coloured by the UK lineage number, and 
Figure 5 (bottom) a heat map of the number of sequences from Scotland arranged into 
lineages – each horizontal line is a lineage, the colour at each epi-week representing the 
number of sequences. This shows there were many lineages which have sequences in 
Scotland before mid-July  but these die out (388 of which 66 with size > 5 before epi-week 
30), being replaced by lineages associated with new introductions by the end of August (epi-
week 36 starts on 30th August 2020). From the end of August onwards, there were 30 new 
lineages with sequences in Scotland although only one had more than five sequences. 
 
 
Figure 5. Re-emergence of SARS-CoV-2. UK lineages circulating in Scotland in first and second 
waves. Top | Number of sequences from Scotland, coloured by UK lineage number. Bottom | Heat 
map of sequences from Scotland in lineages by epi-week (minimum value = 1: pale green; maximum 
value = 169: bright magenta/red)  
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The second wave -- persisting UK lineages in Scotland. There were 13 UK lineages which 
have sequences in Scotland (nine with more than five sequences) detected before epi-week 
30 and also after epi-week 36 (see Supplementary table 1 for details). Bar plots of the number 
of sequences in England, Wales, Scotland and Northern Ireland with these UK lineages per 
epi-week are in the Supplementary figure 8. These Supplementary figures show firstly that 
the number of sequences in Scotland in these persisting lineages decrease or go to zero 
between epi-week 30 and 36. Since the number of sequences in Scotland represent a fraction 
of the true number of cases (presumably untested individuals with mild or no symptoms), it 
is important to note these persisting lineages may not have completely died out in Scotland.  
Secondly, however, the supplementary figures show that sequences from England dominate 
in these persisting lineages, although there are sequences from Wales in most of them, and 
from Northern Ireland in a minority – and there were no persisting lineages which contained 
only sequences from Scotland. Thirdly, the total number of sequences in the persisting 
lineages from anywhere in the UK ranged from five (UK650) to 13085 (UK5), with four 
lineages having at least 1000 sequences. 
 
The second wave -- origins and timing of new lineages. Following the easing of lockdown 
since July, and despite the continued implementation of physical distancing, community 
testing and contact tracing, the number of cases and associated lineages of SARS-CoV-2 
has steadily increased (Figure 5). Without access to genome sequence data the origins of 
the second wave cases would be impossible to assess. However, using the 8603 sequences 
available by the 21st Oct 2020 we can compare these variants to those present in the first 
wave (Figure 5). This analysis shows that most of the latter are novel lineages, rather than 
persisting wave one lineages (Figure 5, bottom). Importantly, while some of the wave 2 
lineages are re-introductions from other parts of the UK, the majority are introductions from 
outside of the UK which seed new lineages (Figure 6). Once introduced these lineages have 
grown within Scotland spreading to different regions (Figure 7).  
 
 
Figure 6. Cumulative Plot of the UK lineages present in Scotland through time depicting lineages that went extinct 
over the summer (green), persistent lineages (orange) and wave 2 lineages (blue). The four vertical dashed lines 
represent the beginning of the lockdown (23rd March 2020) and its easing: movement to phase 1 (29th March 
2020), phase 2 (19th June 2020) and phase 3 (10th July 2020).  
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In order to estimate both when, and from where the UK lineages were imported into Scotland, 
time-scaled trees from the 21st Oct 2020 data set were used. As before, each UK lineage 
which had sequences in Scotland was ‘extended’ to include ancestral nodes and other 
sequences subtended from those nodes from the main global tree (see Methods). These 
extended lineages were time-scaled, and a discrete traits model was used to infer which 
region infected which. Here the simplest equal rates discrete trait model was used (most 
similar to parsimony). As previously noted, estimates can be biased by the number of 
sequences in each category, the accuracy of the sub trees, and additionally by the time-
scaling mechanism. Although the sequence numbers only represent a few percent of the true 
number of cases (including untested individuals)  adding additional identical sequences 
sampled in the same epi-week into a lineage will not change the estimate of the origin time 
of the lineage by very much, since this estimate is governed by the maximum diversity of the 
sequences. 
 
Results for the ancestral origin of UK lineages that exist in Scotland (Supplementary figure 6 
and Supplementary table 2) show that by July imports were increasing after the reduction in 
May and June, and there was an apparent peak of imports in August (although the estimation 
method is sensitive to having sufficient data subsequent to August to make this inference). 
We estimate that during the period 17th July to 30th August, there were 46 import events 
from elsewhere into Scotland, which were composed of 28 (61% of events) from England, 13 
(28% of events) from Europe (not including UK), and four from Asia (9%). After August 30th, 
we estimate only nine import events from elsewhere into Scotland with eight of them having 
been detected in England and one from Europe. Considering that the number of sequences 
from England is by far the highest of any country or continent region, it is not surprising that 
there are so many apparent imports from England, but it is noteworthy that there are apparent 
detectable imports into Scotland from Europe and Asia in August. Furthermore, 
epidemiological investigations indicate that 11 of the 13 new lineages from epi-week 29 to 39 
analysed contained sequences from individuals with recorded travel history mostly from 
Europe and a few from England. These independent epidemiological results largely agree 
with the results from the phylogenetic analyses that several lineages in Scotland were seeded 
by European imports and some by English imports over the summer period. 
 
The second wave -- relative contribution of imports to lineages in September. An 
estimate of the relative contribution of the imported lineages to the subsequent circulation in 
Scotland was made by considering which UK lineages were imported in the time periods 17th 
July to 30th August (summer) and 30th August onwards (autumn), and the number of 
sequences within those lineages in Scotland versus the total number of sequences in 
Scotland counting from 17th July onwards for summer imports, or 30th August onwards for 
autumn imports. Supplementary table 3 shows the summary per lineage origin location, and 
Supplementary tables 4 and 5 show the details of the top summer and autumn imported 
lineages. 
There were 2882 sequences collected from Scotland from 17th July onwards, and of the 46 
lineages which had an inferred origin outside Scotland timed between 17th July and 30th 
August, these lineages resulted in 763 sequences in Scotland, so overall it is estimated that 
imported lineages over the summer contributed to 26% of sequences from the summer 
onwards. Interestingly, by this measure it was imports from Europe (16%) rather than 
England (8%) that contributed more to the subsequent number of Scottish sequences over 
the summer and onwards. While, in the autumn, there were 1686 sequences collected from 
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Scotland from 30th August onwards, and of the nine lineages which had an inferred origin 
outside Scotland timed as 30th August and onwards, these lineages resulted in 18 sequences 
in Scotland. So overall it is estimated that imported lineages over the autumn only contributed 
to 1% of sequences from the autumn onwards. Of this 1% the majority of the sequences in 
these lineages had an English origin. 
 
Conclusions. COVID-19 in Scotland was seeded by at least 300 introductions of SARS-
CoV-2 across the country with the majority of imports being from our nearest neighbours 
England and mainland Europe. Scotland in turn exported the virus to multiple geographic 
locations, most notably England, North America and mainland Europe. Within Scotland itself 
the main metropolitan areas were greater contributors to the seeding of SARS-CoV-2 into 
other geographical locations. It is clear that due to the extent the virus was established in 
Scotland by April, without the lockdown infections would likely have continued to spread and 
rise uncontrolled. Notwithstanding the unintended consequences of the lockdown on 
individuals lives, other medical conditions, mental health, education and the economy, it can 
be concluded that this unprecedented public health intervention, not only reduced case 
numbers as is well documented, but led to reductions in the spread of the virus and to the 
extinguishing of multiple fast growing virus lineages. However, it is clear from the genomics 
data that it is imperative to control SARS-CoV-2 re-emergence appropriately once viral 
prevalence has been reduced to low levels. Prevention measures to minimise re-
introductions into the UK and the virus being moved from regions of high to low prevalence 
are important. SARS-CoV-2 is established in the human population and until a vaccine or 
effective drugs are available, non-pharmaceutical interventions are all we have to control the 
virus, and therefore it is paramount that the lessons learned about their effectiveness are 
heeded for future public health benefit. 
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Figure 7. Maps showing the import and export relationships between the Health Boards within 
Scotland at different timepoints from July to October. A time lapse video is available at 
http://phylodynamics.lycett.roslin.ed.ac.uk:3838/RiseFallScotCOVID/ Results for Orkney, Shetland 
and the Western Isles are not included as sequence numbers are too low for these regions. 
 
Methods 
Data acquisition. SARS-CoV-2 positive samples were obtained by the Royal Infirmary of 
Edinburgh and the MRC-University of Glasgow Centre for Virus Research (CVR) from the 
eleven Health Boards of Scotland. Viral genome sequences were obtained (see below), 
combined with others from across the UK and with genomes from other countries also 
deposited in GISAID (Supplementary table 1). All known high quality genomes in GISAID 
were initially processed. As of 2020-08-18 these consist of 72401 genomes in total, of which 
35744 were from the UK (approximately 50% of the global sample) and 5137 were from 
Scotland (7% of the global sample, and 14% of the whole UK sample; and 26.5% of the total 
positive tests in Scotland). The global data set contained sequences sampled from 2019-12-
24 to 2020-08-10, of which Scottish sequences were from 2020-02-28 to 2020-08-05, the 
later a few weeks after the time lockdown restrictions started to be relaxed (taken to be 2020-
07-10). To study the second wave SARS-CoV-2 genome data available until the 2020-10-21 
was analysed. 
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Samples. Samples were obtained from all Scottish Health Boards following ethical approval 
from the relevant national biorepository authorities (16/WS/0207NHS). The Royal Infirmary 
of Edinburgh and West of Scotland Specialist Virology Centre, NHS GGC conducted 
diagnostic real-time RT-PCR to detect SARS-CoV-2 positive samples , following nucleic acid 
extraction. Residual nucleic acid from samples were sequenced at the Royal Infirmary of 
Edinburgh and the MRC-University of Glasgow Centre for Virus Research (CVR) for whole 
genome next generation sequencing. 
Sequencing, ONT MinION/GridION. Following extraction, libraries were prepared utilising 
protocols developed by the ARTIC network (v1 and v2) and primer versions v1-v3. The 
sequencing protocol and multiplex primers are described in detail at 
https://artic.network/ncov-2019. Library pools were loaded onto R9.4.1 flow cells and 
sequenced in MinION or GridION devices using MinKNOW version 19.12.5 and 19.12.6, 
respectively. The ARTIC nCoV-2019 environment utilising RAMPART v1.0.5 and v1.1.0 was 
used to visualise read mapping in real time. MinION generated raw FAST5 files were 
subsequently base called using Guppy version 3.4.5 in high accuracy mode and using a 
minimum quality score of 7. GridION generated fastq files were also produced utilising live 
high accuracy base calling. Following the ARTIC-nCov-2019 bioinformatics protocol, reads 
were initially size filtered, then demultiplexed and trimmed with Porechop (18), and mapped 
against reference strain Wuhan-Hu-1 (GenBank accession number MN908947.3), followed 
by clipping of primer regions. Variants were called using Nanopolish 0.11.3 (19) and accepted 
if they had a log-likelihood score of greater than 200, and read coverage of at least 20.  
Sequencing, Illumina MiSeq. Samples were processed as described for the ONT workflow, 
until the amplicon generation stage. The resulting DNA fragments were cleaned using 
AMPURE beads (Beckman Coulter) and used to prepare Illumina sequencing libraries with 
a DNA KAPA library preparation kit (Roche) following manufacturer’s instructions. Indexing 
was carried out with NEBNext multiplex oligos (NEB), using 7 cycles of PCR. Libraries were 
pooled in equimolar amounts and loaded on a MiSeqV2 cartridge (500 cycles). The 
PrimalAlign pipeline (https://github.com/rjorton/PrimalAlign) was used to construct the 
consensus. A read coverage of at least 10 was used for the consensus. Some of the samples 
were sequenced at the Wellcome Sanger Institute, following the protocol described in detail 
at protocols.io (https://www.protocols.io/view/covid-19-artic-v3-illumina-library-construction-
an-bibtkann; https://www.protocols.io/view/covid-19-artic-v3-illumina-library-construction-an-
bnidmca6. Briefly, RNA was reversed transcribed using LunaScript RT (NEB) followed by 
amplicon generation using NEB Q5® Hot Start High-Fidelity (NEB) and the ARTIC network 
primers. Following clean up, libraries were prepared using the NEBNext Ultra II DNA Library 
Prep Kit for Illumina (NEB), including end prep, ligation of a TruSeq adapter to the DNA 
fragments, followed by PCR amplification and indexing with KAPA 2x Kapa HiFi Hotstart 
(Roche), and KAPA unique dual indices (Roche). Following quantification and pooling, 
libraries were loaded on a Illumina NovaSeq SP flow cell, using the XP workflow, with 384 
samples per lane. 
Sequence data. Only consensus sequences >90% coverage were included in our analysis. 
All consensus genomes are available from the GISAID database (https://www.gisaid.org), the 
COG-UK consortium website (https://www.cogconsortium.uk/data/) and BAM files from the 
European Nucleotide Archive’s Sequence Read Archive service, BioProject PRJEB37886 
(https://www.ebi.ac.uk/ena/data/view/PRJEB37886).  
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Phylogenetic analysis. Global sequences were obtained from the GISAID Initiative 
https://www.gisaid.org. All UK and global sequences were processed using the COG-UK 
grapevine pipeline https://github.com/COG-UK/grapevine. Briefly, the sequences are aligned 
to the reference sequence Wuhan-Hu_1 (MN908947.3) using minimap2 (Li, 2018) and a 
maximum-likelihood phylogenetic tree is constructed using Fasttree 
http://www.microbesonline.org/fasttree/. PANGOLIN, https://pangolin.cog-uk.io (Rambaut et 
al. 2020), was used for assigning phylogenetic lineages. UK lineages are defined here: 
https://github.com/COG-UK/grapevine/blob/master/docs/lineages.md. Note, the UK lineage 
numbering is dynamic so can change with data updates. TreeTime (Sagulenko, Puller, and 
Neher 2018) was used to estimate a time calibrated phylogeny for all Scottish sequences up 
until 2020-08-18 using a clock rate of 0.001 allowing for up to 10 iterations in the inference 
cycle. Faith’s phylogenetic diversity (Faith 1992) was used to estimate phylogenetic diversity 
by summing the length of the branches for each NHS Health Board for each epi-week.  
 
Phylodynamic analysis. For each UK lineage present in Scotland, the most-recent-
common-ancestor (MRCA) internal node in the tree corresponding to the origin of the Scottish 
sequences was found. Next an ‘extended’ lineage was formed by going two steps backward 
in the tree and then re-extracting the original lineage plus a subsample of the other 
sequences subtended by that ancestral node, resulting in the original clade of Scottish 
sequences embedded in surrounding sequences from elsewhere in the UK and globally. 
Polytomies in the extended lineage were resolved by including very small branch lengths 
(genetic distances of 1x10-12). An approximate time scale for this extended lineage tree was 
estimated using R package Treedater (Volz and Frost 2017). The estimation should be better 
than just estimating on the original lineage because the time-depth of the samples is greater. 
The clade in the extended lineage containing sequences only from Scotland was 
subsequently re-extracted from the time-scaled tree, and the skygrowth package in R was 
used to estimate the effective population size over time, and the growth rate of the lineage 
within Scotland (data shown in R-shiny). Recent travel history for a sample of wave two 
infections were obtained from local public health databases. 
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